Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018

[11] Inubushi M(2018)Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma Ann Nucl Med 32 532-708

[12] Kaneta T(2018)The value of different 18 F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients Ann Nucl Med 32 687-648

[13] Ishimori T(2018)Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [ 18 F]fluoro-borono-phenylalanine PET/CT Ann Nucl Med 32 702-388

[14] Imabayashi E(2018)Predictive value of primary tumor parameters using 18 F-FDG PET/CT for occult lymph node metastasis in breast cancer with clinically negative axillary lymph node Ann Nucl Med 32 642-416

[15] Okizaki A(2018)Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate Ann Nucl Med 32 379-552

[16] Oku N(2018)18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival Ann Nucl Med 32 410-327

[17] Shryock Richard H.(2018)Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer Ann Nucl Med 32 542-310

[18] Sheikh A(2018)Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis Ann Nucl Med 32 319-86

[19] Sollini M(2018)Artificial neural network retrained to detect myocardial ischemia using a Japanese multicenter database Ann Nucl Med 32 303-371

[20] Cozzi L(2018)Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds Ann Nucl Med 32 75-656

[11] Inubushi M(2018)Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma Ann Nucl Med 32 532-708

[12] Kaneta T(2018)The value of different 18 F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients Ann Nucl Med 32 687-648

[13] Ishimori T(2018)Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [ 18 F]fluoro-borono-phenylalanine PET/CT Ann Nucl Med 32 702-388

[14] Imabayashi E(2018)Predictive value of primary tumor parameters using 18 F-FDG PET/CT for occult lymph node metastasis in breast cancer with clinically negative axillary lymph node Ann Nucl Med 32 642-416

[15] Okizaki A(2018)Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate Ann Nucl Med 32 379-552

[16] Oku N(2018)18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival Ann Nucl Med 32 410-327

[17] Shryock Richard H.(2018)Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer Ann Nucl Med 32 542-310

[18] Sheikh A(2018)Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis Ann Nucl Med 32 319-86

[19] Sollini M(2018)Artificial neural network retrained to detect myocardial ischemia using a Japanese multicenter database Ann Nucl Med 32 303-371

[20] Cozzi L(2018)Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds Ann Nucl Med 32 75-656